ADMINISTRATION OF APREPITANT FOR THE PREVENTION OF NAUSEA AND VOMITING IN PREGNANT WOMEN UNDERGOING

Registry ID

2025-12589

Source registry

HEALTH_CANADA

Status

Pending

Study type

INTERVENTIONAL

Sponsor

CENTRE HOSPITALIER DE L'UNIVERSITÉ DE MONTRÉAL

Last update

2023-06-01

Conditions

• CESAREAN DELIVERY
• NAUSEA AND VOMITING

Related clinical trials

• ADDING APREPITANT TO A MULTIMODAL STRATEGY FOR PREVENTING POSTOPERATIVE NAUSEA AND VOMITING IN HIGH-RISK PATIENTS UNDERGOING OUTPATIENT SURGERY
• EFFECT OF CO-ADMINISTRATION OF CARBETOCIN AND CALCIUM CHLORIDE ON UTERINE TONE IN PATIENTS UNDERGOING ELECTIVE CESAREAN DELIVERY: A DOUBLE-BLIND RANDOMIZED CONTROL TRIAL
• A RANDOMIZED CONTROLLED TRIAL COMPARING APREPITANT TO STANDARD OF CARE FOR POSTOPERATIVE NAUSEA AND VOMITING PROPHYLAXIS IN CHILDREN UNDERGOING SCOLIOSIS SURGERY: THE APRE-PONV TRIAL
• RANDOMIZED, DOUBLE-BLIND, PHASE 2/3 STUDY OF IV AMISULPRIDE AS PREVENTION OF POST-OPERATIVE NAUSEA AND VOMITING IN PEDIATRIC PATIENTS
• DEXMEDETOMINE AS ADJUVANT FOR SPINAL ANESTHESIA IN ELECTIVE CESARIAN SECTIONS
• SPINAL HYDROMORPHONE VS. MORPHINE FOR POST CESAREAN DELIVERY ANALGESIA

View on source registry